Meyka AI API is live for developers.Start building.
Advertisement
Pacira BioSciences, Inc.

Pacira BioSciences, Inc. (PCRX) Stock Overview

Explore Pacira BioSciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PCRX●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$25.24
$0.87(3.57%)
U.S. Market opens in 54h 49m
Advertisement

Pacira BioSciences, Inc. (PCRX)

Meyka AI Score

Z

Key Financials

Market Cap992.8M
P/E Ratio204.39
EPS (TTM)$2.61
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$22.03
3 Months$17.52
1 Year Target$22.26

PCRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pacira BioSciences, Inc. (PCRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 68.31, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 204.39 and a market capitalization of 992.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.57%
5-Day Change
13.64%
1-Month Change
3.61%
3-Month Change
8.28%
6-Month Change
-4.79%
Year-to-Date (YTD) Change
-2.47%
1-Year Change
6.45%
3-Year Change
-36.29%
5-Year Change
-58.91%
All-Time (Max) Change
259.54%

Contact Information

https://www.pacira.com
813 553 6680
5401 West Kennedy Boulevard, Tampa, FL, 33609

Company Facts

7,880 Employees
IPO DateFeb 3, 2011
CountryUS
Actively Trading

Frequently Asked Questions